MiMedx Group Inc (MDXG)
Healthcare
Biotechnology
4.10 $
-3.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns MiMedx Group Inc (MDXG)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 79.2% of the shares are freely tradable; institutional investors hold 76.9%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
76.9%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
2.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
79.2%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
6.5%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
149Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Essex Woodlands Health Ventures | 18.93 | 28,195,249 | +0.0 | 03/31/2026 |
| BlackRock Inc | 8.00 | 11,911,300 | +5.1 | 03/31/2026 |
| Vanguard Group Inc | 4.82 | 7,184,262 | +5.6 | 12/31/2025 |
| Trigran Investments Inc | 4.82 | 7,175,109 | +16.4 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.47 | 5,166,006 | +0.0 | 03/31/2026 |
| State Street Corp | 3.40 | 5,056,801 | +32.6 | 03/31/2026 |
| Paradigm Capital Management, Inc. | 2.29 | 3,410,300 | +39.1 | 03/31/2026 |
| Nantahala Capital Management, LLC | 2.28 | 3,397,299 | +40.6 | 03/31/2026 |
| Renaissance Technologies Corp | 2.03 | 3,019,871 | +22.4 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.50 | 3,722,290 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.